Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1817-2026Class II

Cytal Wound Matrix 2-Layer 7x10 cm. Product ID: WSM0710

Integra LifeSciences Corporation / initiated 2026-03-19 / Open, Classified / root cause: sterility

Integra LifeSciences Corp. (NeuroSciences) began a recall of Cytal Wound Matrix 2-Layer 7x10 cm. Product ID: WSM0710 on . FDA classified it as Class II and gives the reason as "Increased rate of out-of-specification endotoxin results". As of , the recall status on record is Open, Classified, and MDM tags the root cause as sterility.

Recall record

Recall number
Z-1817-2026
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Integra LifeSciences Corporation
Product
Cytal Wound Matrix 2-Layer 7x10 cm. Product ID: WSM0710.
Product code
KGN Wound Dressing With Animal-Derived Material(S)
Reason for recall
Increased rate of out-of-specification endotoxin results.
Root cause tag
sterility
FDA root cause
Under Investigation by firm
Action
Integra LifeSciences notified consignees on about 03/19/2026 via letter. Consignees were instructed to identify any affected units on hand and remove them immediately from service and quarantine them, complete and return the Acknowledgment Form and arrange for the return of affected units. Consignees were also instructed to forward to all affected personnel who utilize the product so they are aware of the recall and can identify any affected product that may remain in clinical areas. Distributors were instructed to identify any affected units on hand and remove them immediately from service and quarantine them, complete and return the Acknowledgment Form and arrange for the return of affected units. Distributors were also instructed to check customer traceability records and notify them if they have any shipments with affected units. They requested to modify the acknowledgement form to provide to customers, collect completed response forms and provide those numbers in the distributor reply form. Integra LifeSciences sent a second notification letter on about 03/20/2026, which updated the lot numbers affected. Consignees were asked to disregard the previous letter and replace it with the updated one. Directions for consignees and distributors did not change.
Quantity in commerce
46 units
Distribution
US Nationwide distribution in the states of AL, AZ, CA, DC, FL, GA, IA, IL, KS, KY, LA, MD, ME, MN, MO, MT, NC, ND, NE, NJ, NY, OH, PA, SC, SD, TN, TX, VA, VT, WA, WI, WV.
Product codes and lots
Product ID: WSM0710. UDI-DI: 00386190001448. Lot Numbers: 7579683, 7582225, 7583893, 7582227, 7583933, 7583891, 7591942, 7591944, 7583935, 7594266, 7594288, 7594286, 7593011, 7594284, 7593013.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1817-2026
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1816-2026Class IIOngoingVoluntary: Firm initiated
Z-1817-2026Class IIOngoingVoluntary: Firm initiated
Z-1818-2026Class IIOngoingVoluntary: Firm initiated
Z-1819-2026Class IIOngoingVoluntary: Firm initiated
Z-1820-2026Class IIOngoingVoluntary: Firm initiated